Allan Silber
Chairman chez POINT Biopharma Corp.
Fortune : 5 M $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Neil Fleshner | M | 60 |
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.
Verity Pharmaceuticals, Inc.
 Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON.
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | 8 ans |
| Joe McCann | M | 47 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | 5 ans |
| Jonathan Goodman | M | 56 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | 4 ans |
| Philip Reichmann | M | 66 | 17 ans | |
| Howard M. Glase | M | - |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON.
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | 8 ans |
| Ari Shomair | M | - |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | - |
| Ross Dove | M | 71 | 9 ans | |
| William Demers | M | 66 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 4 ans |
| Gerald Hogue | M | 66 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 4 ans |
| Y. Meyer | M | 60 | 13 ans | |
| Margaret Gilmour | F | 64 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 4 ans |
| Brian Cobb | M | 40 | 7 ans | |
| Justyna Kelly | F | 39 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 3 ans |
| Gerry Hogue | M | - |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation.
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 4 ans |
| David Ludwig | M | 67 | 4 ans | |
| Kelly Sharpe | F | 59 | 4 ans | |
| Michael Gottlieb | M | 45 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 4 ans |
| Michael Thompson | M | - | 1 ans | |
| Peggy Gilmour | F | - |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation.
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 4 ans |
| Barbara Sinsley | F | 61 | 4 ans | |
| Jay Silber | M | - |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | 5 ans |
| Jessica Jensen | F | 44 |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | 4 ans |
| Carolyn Montgomery | F | - | 12 ans | |
| Philip Johnson | M | 59 | 1 ans | |
| Michael Hexner | M | 71 | 8 ans | |
| Chris Bart | M | - | 17 ans | |
| James Sklar | M | 58 | 9 ans | |
| Nicholas Dove | M | 34 | 4 ans | |
| Steven Lane | M | - |
Jewish National Fund of Canada
| - |
| Harry Bloomfield | M | 79 |
Jewish National Fund of Canada
| - |
| Gordon Brooks | M | - | 1 ans | |
| Robert W. Rieder | M | 78 |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | - |
| Chris Anderson | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Stephen A. Weintraub | M | 76 |
C2 Global Technologies, Inc.
 C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 13 ans |
| Morris Perlis | M | 75 | 12 ans | |
| Kirk Dove | M | 68 | - | |
| Mano Thiyagarajah | M | - | 9 ans | |
| Hal B. Heaton | M | 73 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 16 ans |
| Lea Ray | F | 58 | - | |
| David L. Turock | M | 66 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 8 ans |
| Henry Y. L. Toh | M | 66 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 24 ans |
| Bridget Martell | M | 58 | - | |
| J. Barry Rotenberg | M | - | - | |
| Thomas Bermingham | M | - | - | |
| Howard Wortzman | M | - | - | |
| Noah Mintz | M | - | - | |
| Yael Margolin | M | 70 | 2 ans | |
| Emmett DeMoss | M | 87 | - | |
| Gary Martin Clifford | M | 54 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 3 ans |
| Jamie Golombek | M | - | 6 ans | |
| David Lubner | M | 60 | 2 ans | |
| W. Edward Gettings | M | - | - | |
| Rajesh K. Malik | M | 65 | 2 ans | |
| Scott Allen West | M | 54 | 6 ans | |
| Duncan Hannay | M | - | 3 ans | |
| Bill H. Lomicka | M | 86 | 12 ans | |
| Jonathan Steven Reich | M | 60 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 2 ans |
| Paul J. Vessey | M | - | 6 ans | |
| James Brendan Ryan | M | 82 | 10 ans | |
| Samuel Shimer | M | 60 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 14 ans |
| Catherine Moran | F | - | 7 ans | |
| Gary H. Taylor | M | - |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 8 ans |
| Adam Marc Reich | M | 57 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 2 ans |
| Alex Radulovic | M | - |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 17 ans |
| Jonathan Goodman | M | 62 | 7 ans | |
| Ronald Appleby | M | - | - | |
| Tibor Donath | M | - | - | |
| Seymour Temkin | M | 85 | - | |
| Reuben M. Rosenblatt | M | - | 10 ans | |
| John Kaplan | M | - | 7 ans | |
| Carrie Russell | F | - | - | |
| Michael F. Florence | M | - | - | |
| Marissa Lauder | F | - | 4 ans | |
| Lazaro M. DaRocha | M | - | 2 ans | |
| Kathy Guan | F | - | - | |
| Donna Husack | F | - | 3 ans | |
| Daniel Pearlstein | M | - | 2 ans | |
| Myra Rosario Herrle | M | - | 2 ans | |
| Robin Hallett | M | - | - | |
| Sherin Al-Safadi | M | - | - | |
| Chris Horvath | M | - | 1 ans | |
| Marisa Christenson | F | - | - | |
| Madeleine Nicholls | F | - | - | |
| Vaughn Barber | M | - | - | |
| Ronald Lalonde | M | 68 | - | |
| James G. Ducay | M | - |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | - |
| Kenneth L. Hilton | M | 70 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | - |
| Frank J. Tanki | M | 83 |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 1 ans |
| Eric S. Lipscomb | M | - |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | - |
| Kelly Murumets | F | - |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 4 ans |
| Salil Munjal | M | - | 1 ans | |
| David Silverman | M | - |
C2 Global Technologies, Inc.
C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | 1 ans |
| Steven J. Kaufman | M | - | - | |
| Adam Kohn | M | - | - | |
| Robert Adam Levy | M | - | - | |
| Tammy Witherspoon | F | - | - | |
| Eric Philippe Marianne Machiels | M | 57 | 1 ans | |
| Matthew Vincent | M | - | 1 ans | |
| Dave Phillips | M | - | - | |
| Melita Sequeira | F | - | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Canada | 62 | 62,00% |
| Etats-Unis | 53 | 53,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Allan Silber
- Réseau Personnel
